###begin article-title 0
###xml 27 34 <span type="species:ncbi:9606">infants</span>
Respiratory symptoms among infants at risk for asthma: association with surfactant protein A haplotypes
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 209 216 <span type="species:ncbi:9606">infants</span>
We examined the association between single nucleotide polymorphisms (SNPs) in loci encoding surfactant protein A (SFTPA) and risk of wheeze and persistent cough during the first year of life among a cohort of infants at risk for developing asthma.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 642 648 642 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 61 68 <span type="species:ncbi:9606">infants</span>
###xml 118 123 <span type="species:ncbi:9606">child</span>
###xml 231 237 <span type="species:ncbi:9606">infant</span>
###xml 247 253 <span type="species:ncbi:9606">Infant</span>
###xml 462 469 <span type="species:ncbi:9606">infants</span>
Between September 1996 and December 1998, mothers of newborn infants were invited to participate if they had an older child with clinician-diagnosed asthma. Each mother was given a standardized questionnaire within 4 months of her infant's birth. Infant respiratory symptoms were collected during quarterly telephone interviews at 6, 9 and 12 months of age. Due to the association of SFTPA polymorphisms and race/ethnicity, analyses were restricted to 221 white infants for whom whole blood and respiratory data were available. Ordered logistic regression models were used to examine the association between respiratory symptom frequency and SFTPA haplotypes.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1</italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA</italic>
###xml 85 92 <span type="species:ncbi:9606">infants</span>
###xml 289 296 <span type="species:ncbi:9606">infants</span>
The 6A allele haplotype of SFTPA1, with an estimated frequency of 6% among our study infants, was associated with an increased risk of persistent cough (OR 3.69, 95% CI 1.71, 7.98) and wheeze (OR 4.72, 95% CI 2.20, 10.11). The 6A/1A haplotype of SFTPA, found among approximately 5% of the infants, was associated with an increased risk of persistent cough (OR 3.20, 95% CI 1.39, 7.36) and wheeze (OR 3.25, 95% CI 1.43, 7.37).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 92 99 <span type="species:ncbi:9606">infants</span>
Polymorphisms within SFTPA loci may be associated with wheeze and persistent cough in white infants at risk for asthma. These associations require replication and exploration in other ethnic/racial groups.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 666 667 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 825 826 825 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 31 38 <span type="species:ncbi:9606">infants</span>
###xml 553 580 <span type="species:ncbi:12814">respiratory syncytial virus</span>
###xml 582 585 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
Wheeze and persistent cough in infants are serious respiratory symptoms that can be triggered by respiratory infections and/or a variety of environmental exposures [1-3]. Surfactant protein A (SFTPA) is an abundant, multifunctional protein that is secreted by airway epithelial cells and functions as part of the innate immune response. SFTPA may be critical in protecting the lungs from infectious agents and environmental exposures early in life before the acquisition of specific immunity. SFTPA neutralizes respiratory viruses such as influenza and respiratory syncytial virus (RSV) [4,5]. SFTPA also enhances the uptake of bacteria and viruses by phagocytes [6-8]. In addition to its role in protecting the lungs from microorganisms, SFTPA has other important immunomodulatory functions including binding aeroallergens [9].
###end p 11
###begin p 12
###xml 186 193 186 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 197 203 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2</italic>
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 490 497 490 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 501 508 501 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 137 144 <span type="species:ncbi:9606">infants</span>
###xml 155 163 <span type="species:ncbi:9606">children</span>
###xml 312 319 <span type="species:ncbi:9606">infants</span>
###xml 336 339 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
SFTPA's role in protection of the lungs has led to exploration of potential links between SFTPA and diseases of the respiratory tract in infants and young children. Polymorphisms within SFTPA1 and SFTPA2, two functional, highly homologous SFTPA genes [10-12] have been linked to respiratory distress syndrome in infants [13-15], severe RSV bronchiolitis [16], and otitis media [17,18]. In the present study, we used a candidate gene approach to investigate whether polymorphisms within the SFTPA1 and SFTPA2 genes were associated with wheeze and persistent cough during the first year of life among a prospective birth cohort at risk for developing asthma.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Cohort
###end title 14
###begin p 15
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 53 58 <span type="species:ncbi:9606">women</span>
###xml 219 224 <span type="species:ncbi:9606">child</span>
###xml 288 295 <span type="species:ncbi:9606">Infants</span>
Between September 1996 and December 1998, we invited women delivering babies in six hospitals in Connecticut and Massachusetts to participate in a longitudinal study of asthma development if they had at least one other child at home under 12 years of age with physician-diagnosed asthma. Infants enrolled in the cohort were considered at risk for asthma due to their asthmatic siblings. We provide a full description of the methods elsewhere [2,19].
###end p 15
###begin p 16
###xml 456 462 456 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1</italic>
###xml 478 485 478 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 13 20 <span type="species:ncbi:9606">infants</span>
###xml 719 726 <span type="species:ncbi:9606">infants</span>
###xml 738 743 <span type="species:ncbi:9606">Human</span>
Of the 1,002 infants originally enrolled, respiratory symptom data were available for the first year of life for 889. Between the third and fifth year of participation, we made a second visit to the home to collect a blood sample from our cohort subjects. The current analyses are based on a convenience sample of 355 for whom whole blood and complete respiratory symptom data were available. Nucleotide changes at amino acid (aa) 19, aa 62, and aa 133 in SFTPA1, and aa 223 in SFTPA2 were significantly associated with ethnicity. To prevent identification of invalid associations due to population stratification, we restricted our haplotype analyses to the ethnic group with the largest number of subjects (221 white infants). The Yale Human Investigations Committee and institutional review boards at each participating hospital reviewed and approved the study.
###end p 16
###begin title 17
Data collection
###end title 17
###begin p 18
###xml 61 67 <span type="species:ncbi:9606">infant</span>
###xml 114 120 <span type="species:ncbi:9606">infant</span>
###xml 312 320 <span type="species:ncbi:9606">children</span>
###xml 353 359 <span type="species:ncbi:9606">infant</span>
###xml 503 509 <span type="species:ncbi:9606">Infant</span>
###xml 655 661 <span type="species:ncbi:9606">infant</span>
###xml 861 867 <span type="species:ncbi:9606">infant</span>
###xml 954 960 <span type="species:ncbi:9606">infant</span>
A research assistant visited the home within 4 months of the infant's birth in order to describe the study to the infant's mother, obtain written informed consent, and administer a standardized questionnaire. We collected household demographic data including maternal race and ethnicity, education and number of children; detailed information regarding infant care (e.g. breastfeeding and daycare use); and maternal health status (e.g. self-reported history of allergies or physician-diagnosed asthma). Infant respiratory symptoms were collected during quarterly telephone interviews at 6, 9 and 12 months of age at which time each mother reported on her infant's respiratory symptoms (number of symptom-days per month of wheeze or persistent cough) and doctor or clinic visits (month and year of visit, reason for visit, and diagnosis). Around the time of the infant's first birthday, the mother completed an additional phone questionnaire covering her infant's health status during the previous year.
###end p 18
###begin title 19
Genotyping of SFTPA genes
###end title 19
###begin p 20
###xml 241 248 241 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 275 282 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 376 383 376 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
DNA was extracted from whole blood using the QIAamp DNA blood minikit (Qiagen) according to the manufacturer's instructions. We used sequence specific primer-PCR methodology to genotype the SNPs at aa 19, aa 50, aa 62, aa 133, and aa 219 in SFTPA1 and aa 9, aa 91, aa 223 in SFTPA2 [20]. We used PCR based cRFLP as described by DiAngelo et al. [21] to detect polymorphisms in SFTPA2 at aa 140.
###end p 20
###begin title 21
Data analysis
###end title 21
###begin p 22
###xml 520 527 520 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 530 537 530 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 873 875 871 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 935 937 933 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 952 953 950 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1020 1022 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1047 1054 1045 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 1062 1069 1060 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 1145 1147 1143 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1500 1502 1498 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1503 1505 1501 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1515 1522 1513 1520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 1526 1533 1524 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 1612 1614 1610 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1878 1880 1873 1875 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 1889 1891 1880 1882 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 1891 1893 1882 1884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1902 1905 1893 1896 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 263 270 <span type="species:ncbi:9606">infants</span>
###xml 288 295 <span type="species:ncbi:9606">infants</span>
###xml 362 369 <span type="species:ncbi:9606">infants</span>
Outcomes of interest were respiratory symptom frequency in the first year of life categorized as none or as 1 to 7, 8 to 14, 15 to 21, 22 to 28, or more than 28 days of persistent cough or wheeze. Between 1 and 6 months of symptom information were missing for 18 infants. Data from these infants were included in analyses based on their symptom rates. All other infants had 12 months of complete symptom data. Unadjusted associations between respiratory symptoms and selected study characteristics, SNPs, and individual SFTPA1 or SFTPA2 alleles were evaluated with tests for linear trend (Cochran-Armitage or Somers' D statistic). For statistical tests involving SNPs, frequencies for the minor homozygous allele and heterozygous alleles were combined and compared to the dominant homozygous group. Observed SNP frequencies were tested for Hardy-Weinberg equilibrium by chi2 analyses. We examined pairwise linkage disequilibrium with r2 measures (Fig. 1) using PROC ALLELE of the SAS/Genetics module of SAS version 9.1 [22]. Allele haplotypes for SFTPA1 and for SFTPA2 were assigned and examined for linkage disequilibrium using PROC HAPLOTYPE [22]. We examined the association between haplotype and respiratory symptom frequency (as categorical variables) using ordered logistic regression. Separate analyses were conducted for each symptom and each haplotype compared to all other haplotypes. We estimated the effect of uncertainty in haplotype assignment using a regression calibration technique [18,23] and the SFTPA1 and SFTPA2 haplotype probabilities obtained from PROC HAPLOTYPE. As described previously [18], this technique involved first creating 100 separate haplotype data sets by randomly assigning subject haplotypes based on each subject's haplotype probabilities. Next, 100 separate ordered logistic regression models with coefficient and variance estimates (betai and sigmai 2 for the ith model) were fit for each haplotype of interest. The estimate of the association between the respiratory symptom and the particular haplotype of interest ( ) was calculated as the mean of the 100 regression models. The variability of the estimate was calculated as
###end p 22
###begin p 23
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 130 137 130 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 284 286 284 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 302 304 302 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 186 193 <span type="species:ncbi:9606">infants</span>
Pairwise linkage disequilibrium measure (r2) for surfactant protein A SNPs (5 SFTPA1 SNPs: aa 19, aa 50, aa 62, aa 133, aa 219; 4 SFTPA2 SNPs: aa 9, aa 91 aa 140, aa 223) from 221 white infants at risk for developing asthma. Gray scale represents strength of association from white (r2 = 0) to black (r2 = 1). (CT and MA, 1998 - 2000)
###end p 23
###begin p 24

###end p 24
###begin p 25
###xml 88 89 88 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
where mean () is defined as the mean of the 100 logistic regression variances and var (bis) is defined as the variance of the 100 logistic regression b coefficients.
###end p 25
###begin title 26
Results
###end title 26
###begin p 27
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 25 32 <span type="species:ncbi:9606">infants</span>
###xml 166 173 <span type="species:ncbi:9606">infants</span>
###xml 429 436 <span type="species:ncbi:9606">infants</span>
###xml 441 448 <span type="species:ncbi:9606">infants</span>
###xml 770 777 <span type="species:ncbi:4097">tobacco</span>
Close to half of the 221 infants in our study experienced persistent cough (51%) or wheeze (46%) during their first year of life (Table 1). Thirty-two percent of the infants experienced from 1 to 28 days of persistent cough, 19% experienced more than 28 days of persistent cough during their first year; 36% experienced 1 to 28 days of wheeze and 10% experienced more than 28 days of wheeze during their first year of life. Male infants and infants of asthmatic mothers were more likely to experience persistent cough and wheeze during their first year of life (Table 1). We did not find significant associations with either persistent cough or wheeze and maternal allergies, age daycare attendance began, number of months of breastfeeding, or exposure to environmental tobacco smoke (ETS).
###end p 27
###begin p 28
###xml 126 133 <span type="species:ncbi:9606">infants</span>
Unadjusted associations between personal characteristics and respiratory symptoms during the first year of life for 221 white infants at risk for developing asthma. (CT and MA, 1998 - 2000)
###end p 28
###begin p 29
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 132 139 <span type="species:ncbi:4097">Tobacco</span>
ap-values from test for trend: Cochran-Armitage exact test (1-sided) for gender, maternal allergies, maternal asthma, Environmental Tobacco Smoke (ETS); Somer's D statistic (1-sided) for age when starting daycare and duration of breastfeeding. Significant p-values (p < 0.05) in bold-face type.
###end p 29
###begin p 30
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 185 187 183 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 228 235 226 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 515 516 513 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Table 2 contains unadjusted associations between each of the nine candidate SNPs and persistent cough or wheeze. Individual SNPs were in Hardy-Weinberg equilibrium (p > 0.05 for the chi2 test). Having a C nucleotide at aa 19 in SFTPA1 was associated with greater frequency of wheeze. The G nucleotide at aa 133 was associated with both wheeze and persistent cough during the first year of life. We did not find any significant associations between each of the nine SNPs and personal characteristics listed in Table 1.
###end p 30
###begin p 31
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1</italic>
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2</italic>
###xml 111 113 111 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 153 160 <span type="species:ncbi:9606">infants</span>
Unadjusted associations between SNPs from surfactant protein A alleles (SFTPA1,SFTPA2) and respiratory symptomsa during the first year of life for white infants at risk for developing asthma. (CT and MA, 1998 - 2000)
###end p 31
###begin p 32
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 326 328 326 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 9 16 <span type="species:ncbi:9606">infants</span>
aN = 221 infants had data for persistent cough and N = 219 for wheeze during the first year of life. bp-values from test for trend: Cochran-Armitage exact test (1-sided). Minor homozygotes and heterozygous alleles were combined and compared to the dominant homozygous group. Significant p-values (p < 0.05) in bold-face type. c SNPs were in Hardy-Weinberg equilibrium. rs numbers are given in parentheses next to each amino acid.
###end p 32
###begin p 33
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 68 70 68 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">n </sup>
###xml 76 78 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m </sup>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 187 194 187 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 250 257 250 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 273 275 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
By convention, SFTPA1 and SFTPA2 allele haplotypes are denoted by 6An and 1Am respectively [17,21]. The estimated frequency of each allele haplotype is given in Table 3. The five SNPs in SFTPA1 were in linkage disequilibrium as were the four SNPs in SFTPA2 (p < 0.0001, chi2 test of allelic associations).
###end p 33
###begin p 34
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1</italic>
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2</italic>
###xml 137 139 137 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 275 277 275 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
Unadjusted associations between surfactant protein A (SFTPA1,SFTPA2) haplotypes and persistent cough or wheeze in the first year of life.a Unadjusted odds ratios (OR) and 95% confidence intervals (CI) are from ordered logistic regression models predicting symptom frequency. b (CT and MA, 1998 - 2000)
###end p 34
###begin p 35
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 55 61 55 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 164 171 164 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 223 229 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 281 282 281 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 777 779 777 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 794 801 794 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 836 838 836 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">n </sup>
###xml 842 849 842 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 872 874 872 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m </sup>
###xml 883 884 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 921 922 921 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e</sup>
###xml 19 26 <span type="species:ncbi:9606">infants</span>
###xml 994 1001 <span type="species:ncbi:9606">infants</span>
aAnalyses included infants with complete data for both SFTPA alleles and respiratory symptoms, i.e., for SFTPA1 and persistent cough (N = 203) or wheeze (N = 202); SFTPA2 and persistent cough (N = 205) or wheeze (N = 204); SFTPA and persistent cough (N = 201) or wheeze (N = 200). bSeparate ordered logistic regression analyses were performed for each outcome measure and each haplotype with all other haplotypes serving as the reference group in each model. All model results (ORs [95% CI]) include estimates of model variabillity due to ambiguity in allele haplotype assignment (see text). Number of days per year of symptoms were included in models as a 6-category variable, i.e., 0, 1-7, 8-14, 15-21, 22-28, > 28 days. Significant results (p < 0.05) are in bold-face type. c By convention, SFTPA1 allele haplotypes are denoted by 6An and SFTPA2 allele haplotypes by 1Am [17,21]. daa 62, aa 133 and aa 140 are silent. eEstimated frequency distribution of haplotypes (mean, 95% CI) for white infants.
###end p 35
###begin p 36
###xml 16 23 16 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 102 103 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 175 182 175 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 193 195 193 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0 </sup>
###xml 215 222 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 252 253 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 257 258 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 266 267 266 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 271 272 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 321 328 321 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 53 60 <span type="species:ncbi:9606">infants</span>
The most common SFTPA1 allele haplotypes among white infants in our study population were 6A2, 6A3, 6A4, and 6A in order of decreasing frequency. All others made up 8% of the SFTPA1 alleles. 1A0 was the most common SFTPA2 allele followed in order by 1A1, 1A2, 1A, 1A5, 1A6, and 1A3. All others combined made up 4% of the SFTPA2 alleles.
###end p 36
###begin p 37
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 176 183 176 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 239 246 <span type="species:ncbi:9606">infants</span>
###xml 307 314 <span type="species:ncbi:9606">infants</span>
###xml 457 464 <span type="species:ncbi:9606">infants</span>
Significant associations were found between specific allele haplotypes and frequency of persistent cough or wheeze during the first year of life (Table 3). The 6A haplotype of SFTPA1 was a risk factor for both persistent cough and wheeze: infants with this haplotype (an estimated 6% of this group of white infants) were 3.7 to 4.7 times more likely to experience an additional week of persistent cough or wheeze, respectively, during their first year than infants without this haplotype.
###end p 37
###begin p 38
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 11 18 11 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 196 198 194 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 257 258 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 276 282 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 322 324 320 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 341 342 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 363 370 361 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 374 381 372 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 644 645 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 130 137 <span type="species:ncbi:9606">infants</span>
###xml 413 420 <span type="species:ncbi:9606">infants</span>
###xml 606 613 <span type="species:ncbi:9606">infants</span>
SFTPA1 and SFTPA2 alleles are known to be in strong linkage disequilibrium [24,25]. This was also true in our population of white infants in a general test of allelic associations (p < 0.0001, chi2 test), although pairwise linkage disequilibrium measures (r2) for SNPs within SFTPA reveal a spectrum of associations from r2 = 0 to 0.6 (Fig. 1). An examination of SFTPA1 and SFTPA2 alleles together indicates that infants with the 6A/1A haplotype, an estimated 5.4% of this group, were over 3 times more likely to experience an additional week of persistent cough and/or wheeze during their first year than infants without this haplotype (Table 3).
###end p 38
###begin title 39
Discussion and conclusion
###end title 39
###begin p 40
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 97 103 97 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 292 298 292 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 978 980 978 980 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 981 982 981 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 994 995 994 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 176 183 <span type="species:ncbi:9606">infants</span>
###xml 334 341 <span type="species:ncbi:9606">infants</span>
###xml 496 504 <span type="species:ncbi:9606">children</span>
###xml 573 581 <span type="species:ncbi:9606">children</span>
###xml 603 610 <span type="species:ncbi:9606">infants</span>
###xml 816 823 <span type="species:ncbi:9606">infants</span>
###xml 893 900 <span type="species:ncbi:9606">infants</span>
Results from our study suggest that the 6A allele haplotype of SFTPA1 and the 6A/1A haplotype of SFTPA are associated with increased risk for wheeze and persistent cough among infants at risk for asthma. To our knowledge, this is the first study examining the association of polymorphisms in SFTPA with persistent cough and wheeze in infants. Respiratory symptoms may be triggered by bacterial or viral respiratory infections or exposure to environmental contaminants. This is certainly true for children in our birth cohort [2,3,19]. As reported previously [2], among all children in our birth cohort, infants whose mothers reported respiratory illnesses including bronchitis, bronchiolitis, pneumonia, or croup, were 3 to 5 times more likely to experience persistent cough or wheeze in the first year of life than infants who had no respiratory illness in their first year. Among these same infants, respiratory symptoms have also been linked to household exposures such as NO2 [3] and mold [2,19].
###end p 40
###begin p 41
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 379 402 379 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 473 487 473 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 491 516 491 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae </italic>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 172 179 <span type="species:ncbi:9606">infants</span>
###xml 190 198 <span type="species:ncbi:9606">children</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 379 401 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 473 486 <span type="species:ncbi:727">H. influenzae</span>
###xml 491 515 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
SFTPA likely plays multiple pleiotropic roles in the pathophysiology of the lung. Evidence from animal and human studies suggests an important role for SFTPA in protecting infants and young children during microbial infections early in life. SFTPA deficient mice are impaired in their ability to clear adenovirus from the lung [24]. SFTPA knockout mice show delayed clearance of Haemophilus influenzae [25]. Cell culture assays indicate that SFTPA enhances phagocytosis of H. influenzae and Streptococcus pneumoniae [26].
###end p 41
###begin p 42
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 101 103 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 6 13 <span type="species:ncbi:9606">infants</span>
###xml 158 161 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 305 312 <span type="species:ncbi:9606">infants</span>
###xml 338 345 <span type="species:ncbi:9606">infants</span>
###xml 385 388 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 1121 1124 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
Among infants, polymorphisms in SFTPA have been associated with severe bronchiolitis [16]. The 6A2/1A3 haplotype was associated with increased risk of severe RSV infection (OR 10.4 95% CI 1.3-83.2) and haplotype 6A/1A was protective for severe disease (OR 0.17 95% CI 0.04-0.80). In this study of Finnish infants, cases were hospitalized infants with documented bronchilotis caused by RSV. Controls, matched on sex and age, had no history of respiratory infections requiring hospitalization, but might have had respiratory infections (and symptoms) not requiring hospitalization. Although we identified 6A/1A with increased risk for wheeze and persistent cough, it is interesting that the 6A/1A haplotype is associated with respiratory problems in both populations. Direct comparison between the two studies is difficult because of differences in study design. In our study, "cases" were defined by reported respiratory symptoms. Specific causal agents were not identified, and we did not use hospitalization as a requirement for inclusion. Thus, some of our study subjects could resemble Finnish cases (hospitalized for RSV) or controls (not hospitalized, but possibly suffering from respiratory infection and exhibiting respiratory symptoms).
###end p 42
###begin p 43
###xml 89 111 89 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus fumigatus </italic>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 134 165 134 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dermatophagoides pteronyssinus </italic>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Der p</italic>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 385 391 385 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Der p </italic>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 89 110 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 134 164 <span type="species:ncbi:6956">Dermatophagoides pteronyssinus</span>
###xml 252 258 <span type="species:ncbi:10090">murine</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
SFTPA has been shown to bind to aeroallergens including inhalable extracts from the mold Aspergillus fumigatus [27] and from the mite Dermatophagoides pteronyssinus (Der p) [28]. SFTPA has also been postulated to play a role in allergic asthma [29]. A murine model of asthma indicates that SFTPA mRNA and protein levels increase in response to allergen challenge [30]. SFTPA decreases Der p induced lymphocyte proliferation and histamine release from the blood of atopic donors [31]. SFTPA has also been implicated in bronchial inflammation of sensitized mice [32].
###end p 43
###begin p 44
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 282 283 282 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 646 652 646 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 787 794 787 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 798 805 798 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 896 903 896 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 966 967 966 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 977 978 977 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 996 998 996 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1052 1059 1052 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 1069 1070 1069 1070 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 1090 1091 1090 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 1100 1101 1100 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1125 1127 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1164 1171 1164 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 1212 1219 1212 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
###xml 1223 1230 1223 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA2 </italic>
###xml 4 11 <span type="species:ncbi:9606">infants</span>
###xml 130 137 <span type="species:ncbi:9606">infants</span>
###xml 181 189 <span type="species:ncbi:9606">children</span>
###xml 316 323 <span type="species:ncbi:9606">infants</span>
###xml 703 710 <span type="species:ncbi:9606">infants</span>
###xml 1264 1271 <span type="species:ncbi:9606">infants</span>
###xml 1566 1573 <span type="species:ncbi:9606">infants</span>
All infants in our cohort have at least one sibling with asthma and one-third have asthmatic mothers (Table 1). Two-thirds of the infants have mothers with allergies (Table 1). The children in our cohort experienced high rates of wheeze (46%) during their first year of life (Table 1). Among a cohort of 890 healthy infants in Connecticut and Virginia born between 1993-1996, 33% experienced an episode of wheeze during the winter months of their first year of life [34]. The high rate of wheeze in our study population may reflect the special nature of our cohort: all are considered to be at risk for developing asthma. Along these same lines, SFTPA may play a role in the pathogenesis of asthma, and infants in our cohort, by virtue of their family histories of asthma, may differ in SFTPA1 and SFTPA2 hapylotype distributions compared to the general population. Population based estimates of SFTPA1 allele haplotype frequencies among white Americans are 56.2% 6A2, 24.3% 6A3, 9.3% 6A, 7.6% 6A4 and 2.6% other [33]. Allele haplotype frequencies for SFTPA2 are 53% 1A0, 10.2% 1A, 14.3% 1A1, 7.6% 1A2, and 14.9% all others [33]. With the notable exception of the SFTPA1 allele haplotype 6A, the distribution of SFTPA1 and SFTPA2 haplotypes in our sample of white infants is similar to that of white Americans in the general population. The general population frequency for 6A of 9.3% is higher than the 95% confidence interval for our estimate of 6.1% (95% CI 4.0-8.3), which may indicate a true difference in frequency for this allele haplotype among our group of infants.
###end p 44
###begin p 45
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 440 447 440 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA1 </italic>
The functional significance of specific changes in nucleotide sequence within SFTPA genes has not been well studied. SFTPA is a member of the collectin family and recognizes carbohydrates on the surface of pathogens via their carbohydrate recognition domain [35]. Allele 6A is the only common haplotype in our population with an alanine at aa 19 and a G at aa 133. The SNP at aa 133 is silent, however, aa 19 is in the N terminal region of SFTPA1 and an alanine in this region could conceivably impact binding to pathogens or aeroallergens. Further experiments are needed to identify whether amino acid changes in this region impact the biological properties of SFTPA. Alternatively, the 6A haplotype may simply be a marker for additional uncharacterized functional polymorphisms in our cohort.
###end p 45
###begin p 46
###xml 655 661 655 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 157 163 <span type="species:ncbi:9606">infant</span>
###xml 340 345 <span type="species:ncbi:9606">child</span>
Strengths of this study include the prospective study design and the well characterized demographic, illness, and environmental exposure information for the infant cohort. Mothers in this study were likely capable of accurately reporting respiratory symptoms due to their familiarity with wheeze and persistent cough in the older asthmatic child. Haplotype analyses often use the "most likely" haplotype and seldom include adjustments for uncertainty in haplotype assignment. We used regression calibration techniques that incorporate this uncertainty into estimates of the effect resulting in more conservative estimates of the true associations between SFTPA and persistent cough or wheeze during the first year of life.
###end p 46
###begin p 47
###xml 477 483 477 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFTPA </italic>
###xml 82 89 <span type="species:ncbi:9606">infants</span>
Our results support the importance of SFTPA in modulating respiratory symptoms in infants. Persistent cough and wheeze may result from a variety of exposures and the multifunctional nature of SFTPA indicates that it protects the lung under a variety of conditions. The 6A/1A haplotype may have a functional role in pathogenic processes, or may be linked to unmeasured markers that are causal. Future studies should replicate these observations and examine polymorphisms within SFTPA among additional racial and ethnic groups.
###end p 47
###begin title 48
Competing interests
###end title 48
###begin p 49
The author(s) declare that they have no competing interests.
###end p 49
###begin title 50
Authors' contributions
###end title 50
###begin p 51
MMP conceived of the study, analyzed and interpreted data, and drafted the manuscript. JFG participated in the analysis and interpretation of data, performed the statistical analysis, and helped revise the manuscript for important intellectual content. YZ was involved in the acquisition of data and provided technical support with the genotyping. EWT helped conceive the study, and was involved in the acquisition of data. KB conceived the study, participated in its design and coordination, and helped secure funding. TRH was involved in the critical revision of manuscript for important intellectual content and provided statistical expertise. MMB was involved in the study concept and design, study supervision, critical revisions of the manuscript for intellectual content, and helped obtain funding. BPL was involved in the study concept and design, study supervision, and obtained funding. All authors read and approved the final manuscript.
###end p 51
###begin title 52
Pre-publication history
###end title 52
###begin p 53
The pre-publication history for this paper can be accessed here:
###end p 53
###begin p 54

###end p 54
###begin title 55
Acknowledgements
###end title 55
###begin p 56
###xml 153 165 <span type="species:ncbi:9606">participants</span>
Written consent was obtained from the mothers to participate in this study. This study was made possible by the following hospitals from which our study participants were selected: Yale-New Haven, Danbury, Bridgeport, Hartford (CT), and Bay State (MA). We thank the original 1,002 original families who participated in this study. This study was supported by grants ES07456 and ES05410 from the National Institute of Environmental Health Sciences.
###end p 56
###begin article-title 57
Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence
###end article-title 57
###begin article-title 58
Symptoms of wheeze and persistent cough in the first year of life: associations with indoor allergens, air contaminants, and maternal history of asthma
###end article-title 58
###begin article-title 59
Exposure to NO2 and nitrous acid and respiratory symptoms in the first year of life
###end article-title 59
###begin article-title 60
###xml 57 84 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity.
###end article-title 60
###begin article-title 61
Interactions of surfactant protein A with influenza A viruses: binding and neutralization.
###end article-title 61
###begin article-title 62
###xml 30 57 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Surfactant protein-A enhances respiratory syncytial virus clearance in vivo
###end article-title 62
###begin article-title 63
###xml 27 48 <span type="species:ncbi:1319">group B streptococcus</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice
###end article-title 63
###begin article-title 64
The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity
###end article-title 64
###begin article-title 65
The role of surfactant in asthma
###end article-title 65
###begin article-title 66
###xml 38 43 <span type="species:ncbi:9606">human</span>
Isolation and characterization of the human pulmonary surfactant apoprotein gene
###end article-title 66
###begin article-title 67
The coding sequence for the 32,000-dalton pulmonary surfactant associated protein A is located on chromosome 10 and identifies two separate restriction-fragment length polymorphisms
###end article-title 67
###begin article-title 68
###xml 36 63 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Surfactant protein levels in severe respiratory syncytial virus infection
###end article-title 68
###begin article-title 69
Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome
###end article-title 69
###begin article-title 70
Surfactant protein A and B genetic variants in respiratory distress syndrome in singletons and twins
###end article-title 70
###begin article-title 71
Surfactant protein A gene locus and respiratory distress syndrome in Finnish premature twin pairs
###end article-title 71
###begin article-title 72
###xml 63 90 <span type="species:ncbi:12814">respiratory syncytial virus</span>
###xml 104 111 <span type="species:ncbi:9606">infants</span>
Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants
###end article-title 72
###begin article-title 73
Surfactant protein-A gene locus associated with recurrent otitis media
###end article-title 73
###begin article-title 74
###xml 71 78 <span type="species:ncbi:9606">infants</span>
Association of surfactant protein A polymorphisms with otitis media in infants at risk for asthma
###end article-title 74
###begin article-title 75
Levels of household mold associated with respiratory symptoms in the first year of life in a cohort at risk for asthma.
###end article-title 75
###begin article-title 76
###xml 41 46 <span type="species:ncbi:9606">human</span>
A single round PCR method for genotyping human surfactant protein (SP)-A1, SP-A2, and SP-D gene alleles
###end article-title 76
###begin article-title 77
###xml 78 83 <span type="species:ncbi:9606">human</span>
Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles
###end article-title 77
###begin article-title 78
SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection
###end article-title 78
###begin article-title 79
Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung
###end article-title 79
###begin article-title 80
Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages
###end article-title 80
###begin article-title 81
###xml 11 14 <span type="species:ncbi:10116">rat</span>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 56 77 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia.
###end article-title 81
###begin article-title 82
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 66 96 <span type="species:ncbi:6956">Dermatophagoides pteronyssinus</span>
 Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens.
###end article-title 82
###begin article-title 83
Surfactant proteins SP-A and SP-D as modulators of the allergic inflammation in asthma
###end article-title 83
###begin article-title 84
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 104 119 <span type="species:ncbi:10090">transgenic mice</span>
Interleukin-5-mediated allergic airway inflammation inhibits the human surfactant protein C promoter in transgenic mice
###end article-title 84
###begin article-title 85
###xml 129 137 <span type="species:ncbi:9606">children</span>
Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma
###end article-title 85
###begin article-title 86
###xml 112 118 <span type="species:ncbi:10090">murine</span>
Allergen-induced bronchial inflammation is associated with decreased levels of surfactant proteins A and D in a murine model of asthma
###end article-title 86
###begin article-title 87
###xml 0 6 <span type="species:ncbi:9606">Infant</span>
Infant Respiratory Symptoms Associated with Indoor Heating Sources
###end article-title 87
###begin article-title 88
###xml 9 14 <span type="species:ncbi:9606">human</span>
Study of human SP-A, SP-B and SP-D loci: allele frequencies, linkage disequilibrium and heterozygosity in different races and ethnic groups.
###end article-title 88
###begin article-title 89
Lung surfactant proteins involved in innate immunity
###end article-title 89

